Clinical Trials Logo

Clinical Trial Summary

This study will comprise the first pilot clinical trial of 3D, ultrasound-based thermal ablation control using echo decorrelation imaging, directly testing the capability of this approach to ensure reliable tumor treatment. The purpose of this study is to determine the ability of ultrasound echo decorrelation to successfully predict complete ablation of human hepatocellular carcinoma, concomitant diseased liver, and metastatic liver cancer and to determine the potential of echo decorrelation imaging to provide effective real-time control of radiofrequency ablation (RFA) in liver tumors.


Clinical Trial Description

To rigorously test the feasibility of 3D echo decorrelation imaging to improve the reliability of clinical thermal ablation, decorrelation-controlled ablation will be assessed in a pilot treat-and-resect study. Patients previously scheduled for resection of metastatic liver tumors or benign liver tumors physiologically similar to hepatocellular carcinoma (HCC) (e.g., hepatocellular adenoma or focal nodular hyperplasia) will first undergo radiofrequency ablation (RFA) of their tumors, with real-time, 3D ultrasound echo decorrelation imaging of the treated region performed throughout each ablation. RFA will be performed in the same surgical procedure as the scheduled tumor resection, immediately prior to resection. Patients will be enrolled in two arms, the first undergoing RFA controlled by the RFA generator using manufacturer-specified algorithms, and the second undergoing RFA with echo decorrelation imaging providing an additional stopping criterion. For both arms, 3D maps of ablation zones will be constructed from stained tissue sections and rigidly registered to volumetric ultrasound images using the known tumor position and orientation relative to the ultrasound image volume. Overall ROC curves for prediction of local treatment will be constructed using point-by-point comparison of 3D echo decorrelation images to the mapped ablation zone. The ability of echo decorrelation to predict and control clinical thermal ablation of human liver tumors will be directly tested by assessing and statistically comparing outcomes of the two study arms, including ROC curves, ablation volume and rate, and conformity to planned ablation zones. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05211388
Study type Interventional
Source University of Cincinnati
Contact UCCC Clinical Trials Office
Phone 513-584-7698
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date March 1, 2022
Completion date March 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT04241887 - Is Thoracic Paravertebral Block a Better Option Than Conscious Sedation for PRFA of Liver Tumors N/A
Recruiting NCT04274868 - Pediatric Hepatic Tumors
Completed NCT02985034 - Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT N/A
Recruiting NCT02424955 - Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation N/A
Active, not recruiting NCT05128890 - Evaluation of Resection Techniques for Pancreatic Tumors
Not yet recruiting NCT05370001 - Endotracheal Tube Size Effect on the Carbon Dioxide Washout During Jet Ventilation N/A
Recruiting NCT03579199 - Practical Application of Indocyanine Green Camera in Laparoscopic Liver Surgery N/A
Recruiting NCT04573881 - The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER) N/A
Completed NCT02958592 - Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study N/A
Recruiting NCT02203409 - Laparoscopic Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
Enrolling by invitation NCT03739164 - Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)
Completed NCT02849015 - Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver Phase 1/Phase 2
Recruiting NCT04572633 - The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy N/A
Completed NCT02018107 - PET/CT-Assessment of Liver Tumor Ablation N/A
Recruiting NCT01677728 - Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases N/A
Active, not recruiting NCT03783871 - NeuWave HCC China Study N/A
Enrolling by invitation NCT01812577 - Paravertebral Block for Percutaneous Radiofrequency Ablation of Liver Lesions
Not yet recruiting NCT05161624 - Accuracy Evaluation of Artificial Intelligence Assisted Liver Tumor Ablation Path Planning
Completed NCT02226666 - Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration N/A
Recruiting NCT04812054 - Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death N/A